Intracameral moxifloxacin
also appears to be effective in
reducing the rate of endoph-
thalmitis, according to a 2017
retrospective study of more
than 600,000 surgeries that
was published in
Ophthalmology
(osmag.net/TFngS7).
Moxifloxacin is preferred by
some surgeons given its
accessibility and due to the
concern for hemorrhagic
occlusive retinal vasculitis
(HORV), a severe vision-
threatening inflammatory
reaction associated with use
of intracameral vancomycin.
There are still no FDA-
approved intracameral
antibiotics on the market, so surgeons who choose to use these drugs
must either compound the medication on site or purchase compound-
ed formulations from an outside pharmacy. To ensure that your intra-
cameral antibiotics are safely and properly prepared, partner with an
accredited compounding pharmacy that is compliant with current
Good Manufacturing Practices (cGMP) and has a track record of safe-
ty.
• Post-op drops. Although there is no level 1 evidence supporting
the use of post-operative antibiotic drops, many surgeons do still
prescribe them. Surgeons should always discuss the signs and symp-
N O V E M B E R 2 0 1 9 • O U T PA T I E N T S U R G E R Y. N E T • 1 2 5
• BASE COAT Painting individual eyelashes with povidone-iodine is a
best practice that has been proven to reduce endophthalmitis risks.
Pamela
Bevelhymer,
RN,
BSN,
CNOR
